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Abstract 
Objective: The mortality of re-bleeding 
is high and patients surviving are usually 
in poor clinical condition and have a worse 
outcome than patients with single bleed. 
We performed an update systemic review 
and Meta-analysis to determine the most 
common risk factors for re-bleeding in 
aneurysmal subarachnoid hemorrhage 
patients.  
Method: We reviewed all publications 
on the risk factors of the re-bleeding or re-
rupture of already bled intracranial 
aneurysms. This Meta analysis included 
studies published from the year 2000 until 
2013. Pooled mean difference was 
calculated for the continuous variables 
(Age), and pooled odds ratio (OR) was 
calculated for categorical factors. 
Heterogeneity was tested first. If it is 
significant (p<0.05), random effect model 
was applied, otherwise, fixed model was 
used. Software - Review manager was used 
to find pooled effects and perform 
significant test for each potential risk 
factor. 
 
Results: We identified 174 articles. Only 
7 retrospective studies had met the 
inclusion criteria, with 2470 patients, 283 
patients had aneurysmal re-bleeding. The 
weighted average rate of re-bleeding is 
11.3% with 95% confidence interval [CI]: 
10.1-12.6. Statistically significant risk factor 
for re-bleeding were sex (OR 1.46; 95% 
CI: 1.11, 1.92), high systolic blood pressure 
[SBP] (OR 2.52; 95% CI: 1.40, 4.53), 
aneurysm size (OR 3.00; 95% CI: 2.06-
4.37), clinical condition (Hunt & Hess) 
(OR 4.94; 95% CI: 2.29, 10.68), and Fisher 
Grade (OR 2.29; 95% CI: 1.45, 3.61).  
Conclusion: Sex, high SBP, high Fisher 
Grade, aneurysm size larger than 10 mm, 
and patients with poor clinical condition 
(Hunt & Hess) were independent risk 
factors for aneurysmal re-bleeding. The 
importance of early aneurysm intervention 
should be emphasized to eliminate the risk 
of re-bleeding and poor outcome. 
Key words: Cerebral aneurysm, 
Subarachnoid hemorrhage, re-bleeding, 
risk factor, Meta-Analysis. 
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Introduction 
10-15% of patients with aneurysmal 
SAH die before reaching medical care [1]. 
A further 5% die within the first 24 hours 
of SAH. By the 30th day of SAH, the 
overall case fatality rate increases to nearly 
50% [1] [2]. Of the survivors 25–30% of 
patients re-bleed within the first four 
weeks from the SAH. After the first six 
weeks of SAH, the re-bleeding rate is 
about 4% per year. 50~90% of re-bleeding 
episodes occur in the first 6 hours after the 
primary bleed [3] [4]. Mortality is reported 
to be as high as 75%~80% in patients who 
re-bled from their aneurysm [5] [6] [7] [8]. 
The rate of re-bleeding will be high if the 
aneurysm left untreated. 25% die as a 
result of medical complications of SAH 
[9], like neurogenic pulmonary edema and 
neurogenic stunned myocardium. For 
these reasons, early detection and accurate 
evaluating the incidence of re-bleeding, 
predictors for re-bleeding is mandatory. 
Factors associated with aneurysm re-
bleeding are still controversial. Re-bleeding 
can occur before the patients are admitted 
or during transfer to the hospital [10] 
[11]or after hospitalization. 
 In this study we included parameters 
that were available after admission. We 
had reviewed 9 factors that may have 
significant impact on re-rupture after 
primary bleeding. These findings could 
give neurologists, neurosurgeons, and 
health care providers with most common 
risk factors for re-bleeding in subarachnoid 
hemorrhage patients.  
Method 
We reviewed all publications on the risk 
of the re-bleeding or re-rupture of already 
bled intracranial aneurysms. This Meta 
analysis included studies published from 
the year 2000 until 2013.We performed a 
MEDLINE, EMBASE, COCHRANE, Web 
of Science search. The following keywords 
were used in different combination: 
Cerebral aneurysms, Intracranial 
aneurysms, re-bleeding, re-rupture, 
recurrent hemorrhage, risk factors. We 
searched the reference lists for all relevant 
publications for additional studies, and the 
references of the publications thus found 
were checked again.  
Inclusion criteria:  
1- Patients with SAH due to aneurysmal 
re-rupture after previous bleeding, proved 
by imaging studies such as magnetic 
resonance image (MRI), computed 
tomography angiography (CTA), digital 
subtraction angiography (DSA). 2- studies 
comparing multi risk factors in re-bleeding 
and non re-bleeding groups such as: Sex, 
age, clinical conditions at admission (Hunt 
& Hess), hypertension, location of 
aneurysm, multiple aneurysms, size of 
aneurysm, Fisher Grade, external ventricle 
drainage (EVD).  
Exclusion criteria:  
1- fewer than 20 patients were included, 
because smaller studies are more likely to 
suffer from selection bias. 2- multiple 
reports were published for the same study 
population. 3-the article was a review, a 
case report, or editorial. 4- SAH due to 
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non aneurysmal pathology (trauma, AVM, 
etc.). 5-non English language articles.  
Data extraction:  
Two reviewers independently extracted 
data from the studies that met the 
inclusion criteria. Information was 
extracted on patient, aneurysm 
characteristics, pre-operative treatment. In 
case of disagreement between the 2 
reviewers, consensus was reached by joint 
review. 
 The location of the aneurysms was 
classified as follows (1): anterior 
circulation: anterior communicating artery, 
internal carotid artery, anterior cerebral 
artery, middle cerebral artery, posterior 
communicating artery. (2) posterior 
circulation: vertebral artery, basilar artery, 
posterior cerebral artery. 
 Because in the studies different cut 
points were used for aneurysm size, we 
made the following categories: ≥10mm 
and < 10mm. Others factors were classified 
as follow: Hunt & Hess: IV-V and I-II-III, 
Fisher Grade: ≥3 and < 3. 
Measurements index:  
Age, sex, hypertension, aneurysm 
location, multiple aneurysms, size, Hunt & 
Hess, Fisher Grade and external ventricle 
drainage.  
Data analysis:  
1.  Data (9 factors) were extracted from 
the 7 papers and entered into excel sheet. 
2. Software - Review manager was used 
to find pooled effects and perform 
significant test for each potential risk 
factor. 
3. Pooled mean difference was 
calculated for the continuous variables 
(Age), and pooled odds ratio was 
calculated for categorical factors.  
4. Heterogeneity was tested first. If it is 
significant (p<0.05), random effect model 
was applied, otherwise, fixed model was 
used.  
Results  
We identified 174 articles. Only7 
retrospective studies had met the inclusion 
criteria, with 2470 patients, 283 patients had 
aneurysmal re-bleeding (Table 1). And we 
made a quality evaluation to every research by 
use of the Newcastle-Ottawa Scale (NOS). 
Results of quality evaluation shown most of 
seven researches had high quality (Table 2). 
The weighted average rate of re-bleeding is 
11.3% with 95% confidence interval: 10.1-
12.6. 
Meta-analysis result 
Sex (OR 1.46; 95% confidence interval 
[CI]: 1.11, 1.92), high systolic blood 
pressure [SBP] (OR 2.52; 95% CI: 1.40, 
4.53), aneurysm size (OR 3.00; 95% CI: 
2.06-4.37), clinical condition (Hunt & 
Hess) (OR 4.94; 95% CI: 2.29, 10.68), and 
Fisher Grade (OR 2.29; 95% CI: 1.45, 
3.61). Whereas age, aneurysm location, 
multiple aneurysms and external 
ventricular drainage (EVD) in this analysis 
are not significant risk factors for re-
bleeding in aneurysmal SAH patients 
(Table 3).  
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TABEL 1 
Overview of the 7 included studies 
 Author Publication 
year 
Patient No# Rebleeding 
rate 
 
Study period 
(year) 
design Diagnosis 
Of rebleeding 
Journal Details of 
patient 
selection  
total Rebleed No-rebleed 
KC Cha et 
al. 
2010 492 38 454 8.4% 12 
(1995-2007) 
Retrospective CT J. Korean 
Neurosurg Soc 
No 
Beck et al. 2006 237 23 214 10.7% 3  
(1999-2002) 
Retrospective CT Stroke No 
Lie Mei 
Guo et al. 
2013 326 70 256 27.3% 9.3 
(2002-2010) 
Retrospective CT or lumbar 
puncture 
World 
Neurosurg 
No 
Cong W. 
et al. 
2012 458 63 395 15.9% 3 
(2005-2008) 
Retrospective CT Turkish 
Neurosurgery 
Yes 
Naidech et 
al. 
2005 574 40 534 7.5% 6 
(1996-2002) 
Retrospective CT Arch Neurol Yes 
Ohkuma 
Et al. 
2001 273 37 236 15.7% 10 
(1989-1998) 
Retrospective CT Stroke Yes 
Wu TC. et 
al. 
2012 110 12 98 12.2% 3 
(2007-2010) 
Retrospective CT J. comput assist 
Tomogr 
Yes 
 Total    2470 283        
 
TABEL 2 
The risk factors of the studies and quality evaluation in the meta-analysis 
Authors Risk Factor Scores  
KC Cha et al. A B C D E F G H       7 
Beck et al. A B F H I       8 
Lie Mei Guo et al. A B C D F G H       8 
Cong W. et al. A B C D E G       8 
Naidech et al. G I       8 
Ohkuma et al. A B C D G       7 
Wu TC. et al. A B C D F H       7 
 
TABEL 3 
Meta – analysis 
Factor Number 
of studies 
Heterogeneity 
chi-squared 
Models of   
meta-analysis 
Pooled 
OR/odd 
ratio 
95%CI Z P 
P I2(%) 
Age (mean) 6 0.009 67 Random 1.72 -1.61-5.04 1.01 0.31 
Sex  
Male vs. female  
6 0.61 0 Fixed  1.46 1.11-1.92 2.71 0.007 
Hypertension 4 0.01 72 Random 2.52 1.40-4.53 3.08 0.002 
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Location  
Anterior circulation vs. 
posterior circulation 
5 0.83 0 Random 1.59 0.72-3.48 1.15 0.25 
 Multiple aneurysms 2 0.12 58 Fixed 1.11 0.58-2.09 0.31 0.76 
Size 
≥10mm vs. < 10mm. 
4 0.11 50 Fixed 3.00 2.06-4.37 5.74 0.00001 
Hunt-Hess grade  
IV-V vs.  I-II-III 
5 0.0001 83 Random 4.94 2.29-10.68 4.07 <0.0001 
Fisher grade 
≥3 vs. ＜3 
4 0.34 11 Fixed 2.29 1.45-3.61 3.55 0.0004 
External ventricular  
drainage (EVD) 
2 0.03 78 Random 2.96 0.86-10.22 1.72 0.09 
Meta-analysis result 
 
1. Re-bleeding and age:  
There are 6 studies describing age and re-bleeding. Pooled effects: OR (95% CI): 1.72 (-1.61, 5.04), P-values for pooled 
effect: 0.31, P ˃0.05, there is no statistical difference between the subgroups. 
 
 
2. Re-bleeding and sex:  
There are 6 studies describing sex and re-bleeding. Pooled effects: OR (95% CI): 1.46 (1.11, 1.92), P-values for pooled effect: 
0.007, P＜0.05, there is significant statistical difference between the subgroups. 
 
Study or Subgroup
KC Cha 2010
Beck 2006
Lie Mei2013 
Cong W2012
Naidech 2005
Ohkuma 2001 
Wu 2012
Total (95% CI)
Total events
Heterogeneity: Chi² = 3.60, df = 5 (P = 0.61); I² = 0% 
Test for overall effect: Z = 2.71 (P = 0.007) 
Events
21
11
31
32
0
17
6
118
Total 
38
23
70
63
0
37
12
243
Events
161
87
99
147
0
73
33
600
Total 
454
214
256
395
0
163
65 
1547 
M-H, Fixed, 95% CI
2.25 [1.15, 4.38]
1.34 [0.56, 3.17]
1.26 [0.74, 2.15]
1.74 [1.02, 2.97]
Not estimable
1.05 [0.51, 2.15]
0.97 [0.28, 3.32]
1.46 [1.11, 1.92]
Rebleeding No-rebleeding Odds Ratio Odds Ratio
M-H, Fixed, 95% CI
0.2 0.5 1 2 5
Female Male
Study or Subgroup 
KC Cha 2010 
Beck 2006
Lie Mei2013
Cong W2012
Naidech 2005 
Ohkuma 2001
Wu 2012
Total (95% CI)
Heterogeneity: Tau² = 10.43; Chi² = 15.33, df = 5 (P = 0.009); I² = 67%
Test for overall effect: Z = 1.01 (P = 0.31)
Mean 
51.7 
52 
58.2 
55 
0 
61.2 
57 
SD
11.22 
15.8 
8.99 
20 
0
12.1 
18 
Total 
38 
23 
70 
63 
0
37 
12 
243
Mean 
53.69 
53.6 
52.07 
53 
0
58.6 
56.5 
SD
12.06 
13.7 
10.15 
17 
0 
12.3 
15.6 
Total
454
214
256
395
0 
236
98 
1653 
IV, Random, 95% CI 
-1.99 [-5.73, 1.75] 
-1.60 [-8.31, 5.11] 
6.13 [3.68, 8.58] 
2.00 [-3.22, 7.22] 
Not estimable 
2.60 [-1.60, 6.80] 
0.50 [-10.14, 11.14] 
1.72 [-1.61, 5.04] 
Rebleed No-rebleeding Mean Difference Mean Difference 
IV, Random, 95% CI
-10 -5 0 5 10 
Bleeding patient Young Bleeding patient Old 
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3. Re-bleeding and Hypertension:  
There are 4 studies describing hypertension and re-bleeding. Pooled effects: OR (95% CI): 2.52 (1.40, 4.53), P-values for 
pooled effect: 0.002, P＜0.05, there is significant statistical difference between the subgroups. 
 
4. Re-bleeding and aneurysm location:  
There are 5 studies describing aneurysm location and re-bleeding. Pooled effects: OR (95% CI): 1.59 (0.72-3.48), P-values 
for pooled effect: 0.25, P˃0.05, there is no significant statistical difference between the subgroups. 
 
 
5. Re-bleeding and multiple aneurysms:  
There are 5 studies describing multi aneurysm and re-bleeding. Pooled effects: OR (95% CI): 1.11 (0.58, 2.09), P-values for 
pooled effect: 0.76, P˃0.05, there is no significant statistical difference between the subgroups. 
 
Study or Subgroup
KC Cha 2010
Beck 2006
Lie Mei2013
Cong W2012
Naidech 2005
Ohkuma 2001
Wu 2012
Total (95% CI)
Total events
Heterogeneity: Chi² = 2.38, df = 1 (P = 0.12); I² = 58%
Test for overall effect: Z = 0.31 (P = 0.76)
Events
1 
0 
0 
12
0 
0 
0 
13
Total 
38
0
0
54
0
0
0
92
Events
38
0
0
60
0
0
0
98
Total 
454 
0 
0 
375 
0 
0 
0 
829
M-H, Fixed, 95% CI
0.30 [0.04, 2.22]
Not estimable
Not estimable
1.50 [0.75, 3.02]
Not estimable
Not estimable
Not estimable
1.11 [0.58, 2.09]
Experimental No-rebleeding Odds Ratio Odds Ratio
M-H, Fixed, 95% CI
0.02 0.1 1 10 50
Favours [experimental] Favours [control]
Study or Subgroup
KC Cha 2010
Beck 2006
Lie Mei2013 
Cong W2012
Naidech 2005
Ohkuma 2001
Wu 2012
Total (95% CI)
Total events
Heterogeneity: Chi² = 0.89, df = 3 (P = 0.83); I² = 0% 
Test for overall effect: Z = 1.15 (P = 0.25)
Events
38
0
66
46
0
35
11
196
Total 
38
0
70
42
0
37
12
199
Events
438
0
230
359
0
225
87 
1339 
Total
454
0
256
315
0
236
98 
1359
M-H, Fixed, 95% CI
2.90 [0.17, 49.23]
Not estimable
1.87 [0.63, 5.53]
Not estimable
Not estimable
0.86 [0.18, 4.02]
1.39 [0.16, 11.83]
1.59 [0.72, 3.48]
Experimental No-rebleeding Odds Ratio Odds Ratio
M-H, Fixed, 95% CI
0.05 0.2 1 5 20 
Others ACA/MCA/ICA/AcomA/PcomA
Study or Subgroup
KC Cha 2010
Beck 2006
Lie Mei2013
Cong W2012
Naidech 2005
Ohkuma 2001
Wu 2012
Total (95% CI)
Total events
Heterogeneity: Tau² = 0.26; Chi² = 10.70, df = 3 (P = 0.01); I² = 72%
Test for overall effect: Z = 3.08 (P = 0.002)
Events
16
0
44
32
0
26
0
118
Total 
38
0 
70
63
0 
37
0 
208
Events
159
0
65
142
0
100
0
466
Total 
454
0
256
395
0
236
0
1341 
M-H, Random, 95% CI
1.35 [0.69, 2.64]
Not estimable
4.97 [2.84, 8.71]
1.84 [1.08, 3.14]
Not estimable
3.21 [1.52, 6.81]
Not estimable
2.52 [1.40, 4.53]
Rebleeing No-rebleeding Odds Ratio Odds Ratio
M-H, Random, 95% CI
0.1 0.2 0.5 1 2 5 10
No Hypertension hypertension
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6. Re-bleeding and size:  
There are 4 studies describing aneurysm size and re-bleeding. Pooled effects: OR (95% CI): 2.91 (1.62, 5.22), P-values for 
pooled effect: 0.0003, P<0.05, there is significant statistical difference between the subgroups. 
 
 
7. Re-bleeding and Hunt & Hess:  
There are 5 studies describing Hunt & Hess and re-bleeding. Pooled effects: OR (95% CI): 4.94 (2.29, 10.68), P-values for 
pooled effect: 0.0001, P < 0.05, there is significant statistical difference between the subgroups. 
 
 
8. Re-bleeding and Fisher Grade:  
There are 4 studies describing Fisher Grade and re-bleeding. Pooled effects: OR (95% CI): 2.29 (1.45, 3.61), P-values for 
pooled effect: 0.0004, P<0.05, there is significant statistical difference between the subgroups. 
 
Study or Subgroup
KC Cha 2010
Beck 2006
Lie Mei2013
Cong W2012
Naidech 2005
Ohkuma 2001
Wu 2012
Total (95% CI)
Total events
Heterogeneity: Chi² = 3.37, df = 3 (P = 0.34); I² = 11%
Test for overall effect: Z = 3.55 (P = 0.0004)
Events
36 
20 
47 
0
0
0
11 
114
Total
38
23
70
0
0
0
12
143
Events
329 
160 
140 
0 
0 
0 
80
709 
Total
454
211
256
0
0
0
98
1019
M-H, Fixed, 95% CI
6.84 [1.62, 28.83]
2.13 [0.61, 7.44]
1.69 [0.97, 2.95]
Not estimable
Not estimable
Not estimable
2.48 [0.30, 20.41]
2.29 [1.45, 3.61]
Rebleeding No-rebleeding Odds Ratio Odds Ratio
M-H, Fixed, 95% CI
0.02 0.1 1 10 50
Fisher grade <3 Fisher grade >=3
Study or Subgroup
KC Cha 2010
Beck 2006
Lie Mei2013 
Cong W2012
Naidech 2005
Ohkuma 2001
Wu 2012
Total (95% CI)
Total events
Heterogeneity: Tau² = 0.63; Chi² = 23.51, df = 4 (P = 0.0001); I² = 83% 
Test for overall effect: Z = 4.07 (P < 0.0001) 
Events
33 
0
31 
12 
26 
24 
0
126
Total 
38
0
70
63
40
37
0
248 
Events
123
0
65
46
133
40
0
407
Total 
454
0
256
395
532
236
0
1873 
M-H, Random, 95% CI
17.76 [6.78, 46.53]
Not estimable
2.34 [1.35, 4.05]
1.79 [0.89, 3.59]
5.57 [2.83, 10.98]
9.05 [4.25, 19.26]
Not estimable
4.94 [2.29, 10.68]
Rebleeding No-rebleeding Odds Ratio Odds Ratio
M-H, Random, 95% CI
0.05 0.2 1 5 20
Score <=III Score >III
Study or Subgroup 
KC Cha 2010 
Beck 2006 
Lie Mei2013 
Cong W2012 
Naidech 2005 
Ohkuma 2001
Wu 2012 
Total (95% CI) 
Total events 
Heterogeneity: Tau² = 0.17; Chi² = 6.04, df = 3 (P = 0.11); I² = 50%
Test for overall effect: Z = 3.58 (P = 0.0003)
Events 
10 
13 
52 
0
0
0
7
82 
Total 
38 
23 
70 
0 
0 
0 
12 
143 
Events 
96 
55 
105
0
0
0
27 
283
Total 
451 
214 
256 
0 
0 
0 
98 
1019 
M-H, Random, 95% CI 
1.32 [0.62, 2.81] 
3.76 [1.56, 9.06] 
4.15 [2.30, 7.50] 
Not estimable 
Not estimable 
Not estimable 
3.68 [1.08, 12.60] 
2.91 [1.62, 5.22] 
Experimental No-rebleeding Odds Ratio Odds Ratio 
M-H, Random, 95% CI 
0.05 0.2 1 5 20 
size small (<10) size large (>=10)
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9. Re-bleeding and EVD:  
There are 2 studies describing EVD and re-bleeding. Pooled effects: OR (95% CI): 2.96 (0.86-10.22), P-values for pooled 
effect: 0.09, P˃0.05, there is no significant statistical difference between the subgroups. 
 
 
Discussion  
10-15% of patients with aneurysmal 
SAH die before reaching medical care [1]. 
A further 5% die within the first 24 hours 
of SAH. By the 30th day of SAH, the 
overall case fatality rate increases to nearly 
50% [ 1, 2]. Of the survivors 25–30% of 
patients re-bleed within the first four 
weeks from the SAH, of these; 
approximately 70% die after the re-bleed 
[5]. After the first six weeks of SAH, the 
re-bleeding rate is about 4% per year. 
50~90% of re-bleeding episodes occur in 
the first 6 hours after the primary bleed [3] 
[4]. The re-bleeding rate in this Meta 
analysis between: 7.5%~27.3%. The 
weighted average rate of re-bleeding is 
11.3% with 95% confidence interval [CI]: 
(10.1, 12.6)%.  
1-Age and sex:  
Advanced age people has poor outcome 
after SAH [12]. Several studies have 
reported that old people has higher 
tendency to re-bleed than the control cases 
[12]. Naidech et al. and Cong W. et al. 
suggested that age was not associated with 
re-bleeding [13] [14]. In our study we did 
not find significant difference between re-
bleeding and non re-bleeding groups. 
 Our analysis showed that re-bleeding 
risk for males was significantly higher than 
for females. This finding was quite 
different from other reports claim that 
female patients are high risk factor [15].  
2-Hunt &Hess Grade:  
 The patient's clinical and neurological 
condition on admission was evaluated by 
famous Hunt and Hess grade system [16]. 
Several studies reported that poor Hunt 
and Hess grade was significantly relate to 
aneurysmal re-bleeding [4] [5] [13] [17] 
[18 ] [19]. Our result does not differ from 
these studies. One study by Inagawa et al. 
could not ﬁnd relation between poor Hunt 
and Hess and re-bleeding [20]. This may 
due poor condition patients were 
frequently intubated, sedated, and 
therefore difficult to diagnosis clinically.  
3-High SBP:  
Naidech et al found that hypertension is 
Study or Subgroup 
KC Cha 2010 
Beck 2006 
Lie Mei2013 
Cong W2012 
Naidech 2005 
Ohkuma 2001 
Wu 2012 
Total (95% CI) 
Total events 
Heterogeneity: Tau² = 0.63; Chi² = 4.65, df = 1 (P = 0.03); I² = 78%
Test for overall effect: Z = 1.72 (P = 0.09)
Events 
0
15 
0
0
29 
0
0
44 
Total 
0 
23 
0 
0 
40 
0 
0 
63 
Events 
0 
118
0 
0 
175
0 
0 
293
Total 
0 
214
0 
0 
534
0 
0 
748 
M-H, Random, 95% CI 
Not estimable 
1.53 [0.62, 3.75] 
Not estimable 
Not estimable 
5.41 [2.64, 11.08] 
Not estimable 
Not estimable 
2.96 [0.86, 10.22]
Rebleeding No-rebleeding Odds Ratio Odds Ratio 
M-H, Random, 95% CI 
0.02 0.1 1 10 50 
Without drainage With drainage 
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not associated with re-bleeding after 
subarachnoid hemorrhage. In a large study 
reported that the re-bleeding rate is 6.9% 
after admission to the hospital, but did not 
find relationship to blood pressure [21]. 
Many other studies found that high blood 
pressure after the initial SAH can lead to 
the risk of re-bleeding [4] [17] [22]] [23]. 
Ohkuma found that re-bleeding is more 
common in patients with high systolic 
blood pressure more than160mmHg [4]. 
Our analysis shows high systolic blood 
pressure is a major risk for re-bleed in 
SAH patients.  
4-Fisher Grade:  
The amounts of clot in the 
subarachnoid space demonstrated on initial 
CT scan. Patients with intracerebral or 
intraventricular hematoma usually present 
with poor clinical condition (high H&H 
grade) and high blood pressure on 
admission. This may be can lead to early 
re-rupture of aneurysm. Reynold et al. 
reported higher incidence of intracerebral 
hematoma in patients with signs of 
repeated aneurysm rupture [24]. The high 
incidence of this bleeding pattern may 
substantially contribute to poor clinical 
condition of patient with repeat SAH. 
Inagawa et al and Lie -Mei Guo et al did 
not find any correlation between Fisher 
Grade and re-bleeding [23] [20]. This is 
differ from our study which shows Fisher 
Grade is a risk factor for re-bleeding.  
5-External ventricular drainage (EVD):  
Acute hydrocephalus is a common 
complication after aneurysmal SAH, needs 
emergent cerebral spinal fluid (CSF) 
drainage. Often results in improvement in 
patient clinical condition. There are many 
conflicting studies that assumed CSF 
drainage can lead to re-bleeding [13] [25] 
[26]. The most accepted theory is that, 
CSF drainage in patients with unsecured, 
recently rupture aneurysm may increase 
the transmural pressure across the 
aneurysm wall, and this may lead to 
increasing likelihood of re-bleeding [27]. 
 Beck et al did not find strong 
correlation between external ventricular 
drainage and re-bleeding [28]. In this 
analysis we did not find that EVD a risk 
factor for re-bleeding in aneurysmal SAH 
patients.  
6-Aneurysm Location:  
Previous studies showed the location of 
the aneurysm was implicated in 
aneurysmal re-bleeding [3] [28], especially 
in the anterior communicating artery 
(AComA), and posterior communicating 
artery (PComA) [29]. Cong W. et al study 
showed posterior circulation aneurysm 
patient is in higher bleeding risk than 
those in the non-posterior circulation [14]. 
 The present study revealed that the 
aneurysm location was not a risk factor for 
re-bleeding. This result agrees with 
previous studies by Lei-Mei Guo and Wu 
et al [23] [30].  
7-Aneurysm Size:  
Most of studies emphasize that 
aneurysm size is a major risk for initial 
rupture [31] [32]. Lei-Mei Guo et al found 
that the probability of re-bleeding in 
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patients with aneurysms larger than 10 
mm was 1.624 fold greater than those with 
aneurysms of 10 mm or less [23], but this 
result is not consistent with other studies 
[22] [17]. 
In this analysis we found that aneurysm 
size has a significant risk on re-bleeding.  
8-Multiple Aneurysm:  
Patients with several aneurysm have 
more fragile vessels wall, that's may prone 
to form multiple aneurysms or prone to re-
bleeding after the aneurysm has already 
ruptured. Some studies showed there was 
no significant difference between re-
bleeding and non re-bleeding in patients 
who harboring multiple aneurysms [14]. 
But Beck et al. reported multiple 
aneurysms patients have a risk of re-
bleeding [28]. In our analysis we did not 
find any correlation between multiple 
aneurysms and re-bleeding.  
Conclusion  
Sex, Hypertension, Hunt and Hess 
grade, aneurysm size, and Fisher Grade are 
major risk for re-bleeding in aneurysmal 
Subarachnoid Hemorrhage patients. We 
did not find any correlation between age, 
EVD, aneurysm location and multiple 
aneurysms and aneurysm re-bleeding. We 
advocate early surgery for primary 
ruptured aneurysm in good clinical 
condition patients to eliminate the risk of 
re-bleeding. Maintained systemic blood 
pressure in a moderate hypertensive range 
(140 to 160 mmHg) also can prevent early 
re-rupture of the aneurysm.  
Limitation of this study  
All the studies are retrospective, the 
data quality could not be monitored. Only 
few studies described inclusion and 
exclusion criteria, each study has different 
study objective, and diagnostic criteria 
could be different from hospital to 
hospital. Risk factors studied vary from 
study to study, with different focus.  
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